Patrocinados
What is Leqembi? The first Alzheimer’s treatment approved today in Saudi Arabia
Posted
Saudi Arabia’s SFDA has approved Leqembi (lecanemab), the Kingdom’s first Alzheimer’s treatment. This innovative drug slows disease progression by targeting beta-amyloid plaques, protein clumps that disrupt brain cell communication. Approved for patients with mild symptoms and specific genetic profiles, Leqembi requires careful monitoring to manage side effects, marking a major step forward in Alzheimer’s care through advanced biotechnology.
Buscar
Categorías
- National
- International
- Business
- Technology
- Health
- Educación
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Heavy rainfall likely in Bagmati and Gandaki today
KATHMANDU: Heavy rainfall is likely in one or two locations within the hilly areas of Bagmati and...
Nepal Rastra Bank publishes today’s foreign exchange rates
KATHMANDU: Nepal Rastra Bank (NRB) has published the official foreign exchange rates for today....
Shrawan 15 being observed today
KATHMANDU: The 15th of Shrawan is being celebrated today with the traditional consumption of...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Spanish
